EUVIMEDEUVIMED entdecken
Crossref

Role of recombinant Histoplasma capsulatum 100‐kilodalton antigen in the diagnosis of histoplasmosis among HIV/AIDS patients: Antigenuria and antibodies detection

María A Toscanini, Carolina Rodríguez Laboccetta, Agustín Videla Garrido, Gladys B Posse, Paula Capece, Ruth M Valdez, Yone A Chacón, Daniel González Maglio iD, Alejandro D Nusblat, María L Cuestas iD

Mycoses · 2023

DOI: 10.1111/myc.13587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2023. Verfasst von María A Toscanini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Farmacia y Bioquímica, Instituto de Nanobiotecnología (NANOBIOTEC), Universidad de Buenos Aires, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Histoplasmosis, Acquired Immunodeficiency Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Agencia Nacional de Promoción Científica y Tecnológica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diagnosing progressive disseminated histoplasmosis (PDH) is still challenging in many countries where this disease is highly endemic. Definitive diagnosis is established by culture and/or by cytology/histopathology but both procedures have limited sensitivity and cultures are time‐consuming. Antibodies detection by immunodiffusion has a low sensitivity in immunocompromised individuals. Commercially available antigen detection assays have high sensitivity in PDH cases; however, they are expensive and only performed in few laboratories.

Aims

To describe the potential use of a novel ELISA for antibodies testing and a dot blot assay for antigen testing for diagnosing PDH using the recombinant 100 kDa protein of Histoplasma capsulatum (Hcp100) and their polyclonal antibodies as novel reagents, respectively.

Methods

Serum and urine samples from a cohort of patients with HIV/AIDS and proven PDH were studied for the detection of anti‐Hcp100 antibodies by ELISA and Hcp100 antigen by dot blot, respectively. Sensitivity, specificity and cross‐reactions with other diseases were estimated for each assay and compared with those obtained using histoplasmin (HMN) as a reagent for antibodies detection by ELISA and immunodiffusion, and using a commercial antigenuria test.

Results

Antibodies detection by the Hcp100 ELISA demonstrated 78.6% sensitivity and 88.4% specificity, versus 85.7% sensitivity and 81.0% specificity for the HMN ELISA and 26.1% sensitivity and 100% specificity for the immunodiffusion assay. Antigen detection by the Hcp100 dot blot demonstrated 89.3% sensitivity and 97.0% specificity versus 82.1% sensitivity and 90.9% specificity for the commercial test.

Conclusion

The immunoassays described herein based on Hcp100 would be a valuable screening tool for diagnosing PDH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistoplasmosisAcquired Immunodeficiency SyndromeHumansHistoplasmaAntigens, FungalEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

Histoplasma capsulatumELISAdot blotprogressive disseminated histoplasmosisrecombinant Hcp100

Substanzen

Antigens, Fungal

Autor:innen und Institutionen

  • Facultad de Farmacia y Bioquímica, Instituto de Nanobiotecnología (NANOBIOTEC), Universidad de Buenos Aires, Buenos Aires, Argentina.
  • CONICET, Instituto de Investigaciones en Microbiología y Parasitología Médica (IMPaM), Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Laboratorio de Micología, Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina.
  • Laboratorio de Micología, Hospital Señor del Milagro de Salta, Salta, Argentina.
  • Facultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Instituto de Estudios de la Inmunidad Humoral (IDEHU), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.

ORCID-Profile: Daniel González Maglio, María L Cuestas

Förderung

  • Agencia Nacional de Promoción Científica y Tecnológica

Zitieren

APA

Toscanini, M. A., Laboccetta, C. R., Videla Garrido, A., Posse, G. B., Capece, P., Valdez, R. M., Chacón, Y. A., González Maglio, D., Nusblat, A. D., & Cuestas, M. L. (2023). Role of recombinant Histoplasma capsulatum 100‐kilodalton antigen in the diagnosis of histoplasmosis among HIV/AIDS patients: Antigenuria and antibodies detection. Mycoses. https://doi.org/10.1111/myc.13587

Vancouver

Toscanini MA, Laboccetta CR, Videla Garrido A, Posse GB, Capece P, Valdez RM, et al. Role of recombinant Histoplasma capsulatum 100‐kilodalton antigen in the diagnosis of histoplasmosis among HIV/AIDS patients: Antigenuria and antibodies detection. Mycoses. 2023. doi:10.1111/myc.13587

BibTeX
@article{Toscanini2023,
  author = {Toscanini, María A and Laboccetta, Carolina Rodríguez and Videla Garrido, Agustín and Posse, Gladys B and Capece, Paula and Valdez, Ruth M and Chacón, Yone A and González Maglio, Daniel and Nusblat, Alejandro D and Cuestas, María L},
  title = {Role of recombinant Histoplasma capsulatum 100‐kilodalton antigen in the diagnosis of histoplasmosis among HIV/AIDS patients: Antigenuria and antibodies detection},
  journal = {Mycoses},
  year = {2023},
  doi = {10.1111/myc.13587}
}
Kostenlos starten →